Alamar Biosciences
- Market cap
- 1.93B
- P/E (TTM)i
- -38.78
- P/Bi
- 6.16
- EPSi
- -0.54
- Div yieldi
- 0.00%
- 52W posi
- 43%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.1 percentage points.
Institutional ownership
- Held by institutions
- 66.68% -0.15pp
- Institutions
- 107 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 23 buys · 13 sells
| Name | Role | Stake |
|---|---|---|
| Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | -- | 15.27% |
| Yuling Luo | Chairperson & CEO | 4.45% |
| Shiping Chen | Founder, COO & Director | 1.04% |
| Timothy White | President | 0.66% |
| Nicholas Naclerio | Independent Director | -- |
| Franklin Witney | Independent Director | -- |
| Robert Ragusa | Director | -- |
| IIF Management Company LLC | -- | -- |
| Justin McAnear | Chief Financial Officer | -- |
| Rebecca Chambers | Independent Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-13 | John Brottem | General Counsel | Other Acquisition | +29,000 | -- |
| 2026-09-13 | John Brottem | General Counsel | Other Derivative Acquisition | +85,000 | $27.99 |
| 2026-08-31 | Robert Ragusa | Director | Other Acquisition | +5,686 | -- |
| 2026-08-31 | Robert Ragusa | Director | Other Derivative Acquisition | +25,599 | $29.36 |
| 2026-04-19 | Nicholas Naclerio | Independent Director | Other Acquisition | +5,686 | -- |
| 2026-04-19 | Franklin Witney | Independent Director | Other Derivative Acquisition | +206,781 | $0.59–7.60 |
| 2026-04-19 | Franklin Witney | Independent Director | Other Derivative Disposition | -206,781 | $0.59–7.60 |
| 2026-04-19 | Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | -- | Other Acquisition | +10,594,547 | -- |
| 2026-04-19 | Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | -- | Derivative Exercise and Sale | -10,594,547 | -- |
| 2026-04-19 | Yuling Luo | Chairperson & CEO | Other Derivative Acquisition | +1,817,853 | $1.53–17.00 |
| 2026-04-19 | Yuling Luo | Chairperson & CEO | Other Acquisition | +76,509 | -- |
| 2026-04-19 | Yuling Luo | Chairperson & CEO | Other Acquisition | +3,088,217 | -- |
| 2026-04-19 | Yuling Luo | Chairperson & CEO | Other Disposition | -113,051 | -- |
| 2026-04-19 | Yuling Luo | Chairperson & CEO | Derivative Exercise and Sale | -2,975,166 | -- |
| 2026-04-19 | Yuling Luo | Chairperson & CEO | Other Derivative Disposition | -1,476,662 | $1.53–7.60 |
| 2026-04-19 | Shiping Chen | Founder, COO & Director | Other Derivative Acquisition | +464,241 | $3.34–17.00 |
| 2026-04-19 | Shiping Chen | Founder, COO & Director | Other Acquisition | +37,220 | -- |
| 2026-04-19 | Shiping Chen | Founder, COO & Director | Other Acquisition | +722,885 | -- |
| 2026-04-19 | Shiping Chen | Founder, COO & Director | Other Disposition | -329,521 | -- |
| 2026-04-19 | Shiping Chen | Founder, COO & Director | Derivative Exercise and Sale | -393,364 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:37:42 · For reference only, not investment advice and not tailored to your situation.